Fingolimod (Gilenya▼): updated advice about the risks of serious liver injury and herpes meningoencephalitis

Liver monitoring requirements and discontinuation criteria for fingolimod have been updated following reports of serious liver injury. Fatal cases of encephalitis and meningitis caused by herpes simplex and varicella zoster viruses have also been reported during treatment.

Medicines and Healthcare products Regulatory Agency